Characterizing idiopathic CD4 lymphocytopenia 30-years after its initial description
1. In this observational study, idiopathic CD4 lymphocytopenia (ICL) was associated with an increased risk of opportunistic infections, malignancy, and...
Epicutaneous immunotherapy is effective at desensitizing toddlers to peanut allergens
1. In this randomized controlled trial, an epicutaneous patch containing peanut protein was more effective than a placebo in raising...
Peresolimab reduces disease severity in adults with rheumatoid arthritis
1. In this randomized controlled trial, there was a significant reduction in the Disease Activity Score of rheumatoid arthritis patients...
Cerebral oximetry monitoring in extremely preterm infants does not reduce mortality
1. In this randomized controlled trial, 72 hours of cerebral oximetry monitoring in preterm infants did not significantly reduce mortality...
Donor sex has no effect on survival in patients receiving red blood cell transfusions
1. In this randomized controlled trial, donor sex did not result in a significant difference in mortality amongst patients receiving...
Video decision support tool improves knowledge in Black implantable cardioverter-defibrillator candidates
1. In this randomized controlled trial, a video decision support tool (VIVID) increased knowledge about sudden cardiac death and implantable...
Closed-loop insulin delivery effectively controls blood glucose in children with type 1 diabetes
1. In this randomized controlled trial, closed-loop insulin delivery was more effective than standard care in keeping blood glucose levels...
Prolonged coffee consumption not associated with daily premature atrial contractions
1. In this case-crossover study, consumption of caffeinated coffee was associated with fewer minutes of sleep per night and increased...
72- and 36-hour fever prevention post-cardiac arrest equivalent in preventing mortality
1. In this randomized controlled trial, there was no significant difference in mortality between participants who received fever prevention for...
Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B
1. Etranacogene dezaparvovec gene therapy was more effective than prophylactic factor IX infusion at reducing annualized bleeding rate amongst patients...
